INFORMATICS SHARED RESOURCE The Informatics Shared Resource (ISR) supports for the cancer center's basic, clinical, and translational research. Formerly known as the Shared Computer Facility, this shared resource's name change reflects the shift in focus of the facility from providing central computing hardware platforms for investigators, to providing services for management and processing of data and information. These services include creating research software, data file management, hardware and software acquisition, and computer-related consultation. The ISR has supported cancer center research by developing web-based database applications for clinical trials, biospecimen research repositories, and various research projects. It provides management of very large genomic experimental data sets, acquisition of hardware, development of software tools to facilitate inter- and intra-institutional collaborative research programs, and assistance with design proposals for research-related computing. The clinical trials applications provide information on available clinical trials, the registration of participants on these trials, and the fully automated reporting of trial adverse events. The biospecimen repository applications provide investigators with information characterizing specimens available for research. Applications and strategies for the storage and retrieval of microarray experimental results were developed. Video conferencing systems were acquired and webbased document sharing applications developed for geographically dispersed research collaborations. Informatics Shared Resource staff consult with investigators to recommend hardware and software, ranging from the desktop units to high performance computing clusters. Recognizing the importance for interoperability of independently developed informatics systems as crucial to the furtherance of cancer research through the sharing of research data and resources, the ISR has been an active participant in the NCI's cancer Biomedical Informatics Grid (caBIG?) since the initiative's inception. This resource has been a funded developer and/or adopter in the Integrated Cancer Research and Tissue Bank and Pathology Tools Workspaces. KCC is among the first cancer centers to deploy caBIG? tools. The shared resource director, Dr. London, is a member of the Data Sharing and Intellectual Capital Work Group. Staff members have served as unfunded participants in the Clinical Trials Management Systems Work Space, to keep abreast of developments in this group for possible adoption at the center. The ISR also supports cancer center programs which relate to research, such as the clinical trials applications, seminar conferencing services and the database application for tracking seminars. These are made available to Jefferson Cancer Network hospitals and cancer center community outreach programs, such as the Buddy Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-11
Application #
8084109
Study Section
Subcommittee G - Education (NCI)
Project Start
2010-06-03
Project End
2013-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
11
Fiscal Year
2010
Total Cost
$201,014
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Magee, Michael S; Abraham, Tara S; Baybutt, Trevor R et al. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res 6:509-516
Chervoneva, Inna; Freydin, Boris; Hyslop, Terry et al. (2018) Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res 27:2581-2595
Capparelli, Claudia; Purwin, Timothy J; Heilman, Shea A et al. (2018) ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Res 78:5680-5693
Nevler, Avinoam; Muller, Alexander J; Cozzitorto, Joseph A et al. (2018) A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2. J Am Coll Surg 226:596-603
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:

Showing the most recent 10 out of 807 publications